1. Pharmaceutical patents, R&D incentives and access to new drugs: new ways of progress at the crossroad

   • Fernando Antoñanzas
   • Carmelo Juárez-Castelló
   • Roberto Rodríguez-Ibeas

   Editorial 24 June 2011 Pages: 393 - 395

2. Largely ignored: the impact of the threshold value for a QALY on the importance of a transferability factor

   • Pepijn Vemer
   • Maureen P. M. H. Rutten-van Mölken

   Original Paper Open access 30 May 2010 Pages: 397 - 404

   

3. Discrimination in waiting times by insurance type and financial soundness of German acute care hospitals

   • Christoph Schwierz
   • Achim Wübker
   • Björn A. Kuchinke

   Original Paper 23 May 2010 Pages: 405 - 416

   

4. Hospital’s activity-based financing system and manager: physician interaction

   • David Crainich
   • Hervé Leleu
   • Ana Mauleon

   Original Paper 25 May 2010 Pages: 417 - 427

   

5. Contractual conditions, working conditions and their impact on health and well-being

   • Silvana Robone
   • Andrew M. Jones
   • Nigel Rice

   Original Paper 25 May 2010 Pages: 429 - 444

6. Comparing top-down and bottom-up costing approaches for economic evaluation within social welfare

   • Tina M. Olsson

   Original Paper 23 May 2010 Pages: 445 - 453

7. Cost of low back pain in Switzerland in 2005

   • Simon Wieser
   • Bruno Horisberger
   • Urs Müller

   Original Paper Open access 05 June 2010 Pages: 455 - 467

   

8. Ageing and health care expenditure in EU-15

   • Mickael Bech
   • Terkel Christiansen
   • Martin Weale

   Original Paper 24 June 2010 Pages: 469 - 478

9. Atrial fibrillation: the cost of illness in Sweden

   • Lisa Ericson
   • Lennart Bergfeldt
   • Ingela Björholt

   Original paper Open access 01 July 2010 Pages: 479 - 487

   

10. Cost-effectiveness of cognitive-behavioral group therapy for dysfunctional fear of progression in cancer patients

    • C. Sabariego
    • M. Brach
    • G. Stucki

    Original Paper 06 August 2010 Pages: 489 - 497